Endra Life Sciences Inc (NDRA)

[apollo1452]

Volume Precedes Price...

NDRA set a record for the highest volume day in its history last Tuesday 1/19/21 with 18 million shares traded only for the record to be broken the very next day with 33 million traded. That wasn't day traders, it was accumulation as witnessed by the share price not only holding but increasing in the following days. NDRA also had 4 Fidelity Funds buying shares for the first time recently. In addition, the NDRAW volume has surged this past week after being DOA in 2020. This is Very Bullish action.

The FDA 510k submission was June 2020 & everyone knows the likely approval is coming sooner than later, whether it is this week or next month. It will be a game changer for NDRA & sales will soon follow.

Tuesday will be the 10th consecutive day closing at $1.00 or above so NASDAQ compliance is in sight...

The funds & investors currently buying NDRA are not scared of the daily chart. Yea, the share price has doubled this past week. Some are waiting for the trap door to open with a major price drop but it hasn't happened. Instead, the share price is rising... Why? Look at NDRA's market capitalization of $88 million...that is tiny. NDRA has leading edge technology in its TAEUS platform that will be 50X cheaper than MRI. NDRA already has a Vietnam distribution agreement signed. NDRA is partnered with GE Healthcare. With FDA 510k approval NDRA will be worth a market cap of $200 million to $300 million.

The daily chart is important but the share volume & market capitalization is where the truth lies...